U.S. markets closed

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
39.99-1.07 (-2.61%)
At close: 4:00PM EDT
39.99 -0.00 (-0.00%)
After hours: 04:17PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close41.06
Open40.34
Bid34.17 x 800
Ask49.92 x 1400
Day's Range39.65 - 41.15
52 Week Range32.04 - 48.37
Volume321,824
Avg. Volume137,581
Market Cap575.508M
Beta (5Y Monthly)1.22
PE Ratio (TTM)N/A
EPS (TTM)-1.89
Earnings DateJul 28, 2021 - Aug 02, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est51.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Introducing Anika Therapeutics (NASDAQ:ANIK), A Stock That Climbed 26% In The Last Year
    Simply Wall St.

    Introducing Anika Therapeutics (NASDAQ:ANIK), A Stock That Climbed 26% In The Last Year

    On average, over time, stock markets tend to rise higher. This makes investing attractive. But if you choose that path...

  • Anika Hosts 2021 Virtual Investor Day
    GlobeNewswire

    Anika Hosts 2021 Virtual Investor Day

    Company details multi-year Joint Preservation strategy for accelerated revenue growth and profitability Updates 2021 directional outlook and 2024 multi-year targets BEDFORD, Mass., June 03, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today will host its 2021 Virtual Investor Day beginning at 9:00am EDT. Cheryl R. Blanchard, Ph.D., President and Chief Executive Officer, and Mike Levitz, Executive Vice Pre

  • Anika to Host its 2021 Virtual Investor Day on June 3, 2021
    GlobeNewswire

    Anika to Host its 2021 Virtual Investor Day on June 3, 2021

    BEDFORD, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to host its 2021 Virtual Investor Day on Thursday, June 3, 2021 beginning at 9:00am EDT. Cheryl Blanchard, President and Chief Executive Officer, and Mike Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will present alongside other members of Anika's executive management team, providing an in-depth overview of its business strategy, product portfolio, R&D pipeline and financial objectives. The event will include presentations followed by a Q&A panel session with senior leadership. A webcast will be available on June 3 and will be available for replay at Investor Relations section of Anika's website, www.anika.com. About Anika Therapeutics, Inc. Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with physicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. For more information, please visit www.anika.com. For Investor Inquiries:Anika Therapeutics, Inc.Mark Namaroff, 781-457-9287Executive Director, Investor Relations and Corporate Communicationsinvestorrelations@anika.com